I'm one of many people, I'm sure, who've been blindsided by IRMAA. I'm trying to plan my 2025 income now to minimize my 2027 Medicare charges. I'm filing single. It seems that no one knows what the ...

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...

Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...

According to Becker's Review, a leading healthcare publication, Memorial Hospital has the opportunity to announce its ...

In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...

Nursing home residents that receive Medicaid benefits may be affected by a change in federal poverty level standards, which are applied to eligibility ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.